The 20 Best Choriocarcinoma Doctors Near Me in Bronx, NY

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.

Tarek Elrafei is an Oncologist in Bronx, New York. Dr. Elrafei is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Breast Cancer, Bone Marrow Aspiration, and Thrombectomy.

Avi Retter is an Oncologist in Bronx, New York. Dr. Retter is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Blood Clots, Anemia, Childhood Iron Deficiency Anemia, and Iron Deficiency Anemia.

Fabio Volterra is a Hematologist in Bronx, New York. Dr. Volterra is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Blood Clots, Hodgkin Lymphoma, and Malabsorption.

Dr. Stein is an Associate Professor of Medical Oncology at Columbia University Medical Center. He is a recognized expert in field of genitourinary oncology – treating patients with prostate, kidney, bladder and testicular cancers. He is also a member of the Experimental Therapeutics program, investigating novel therapies across all solid tumors. In addition to providing standard therapies for the treatment of genitourinary cancers such as hormonal therapy, molecularly targeted therapy and chemotherapy, Dr. Stein leads multiple investigator initiated and industry sponsored clinical trials. Dr. Stein has a particular interest in the development of novel immune therapies for the treatment of prostate cancer, both in men with early recurrence of prostate cancer as well as in men with more advanced prostate cancer. He is also helping to lead two national trials in kidney cancer sponsored by the National Cancer Institute.Dr. Stein received his B.S. in Molecular Biophysics and Biochemistry from Yale University. He earned his medical degree at New York Medical College, receiving the graduation award in oncology for his published research. He completed a residency in internal medicine at Montefiore Medical Center, and a fellowship in Hematology and Medical Oncology at Mount Sinai Medical Center. Prior to joining Columbia University, Dr. Stein practiced genitourinary oncology for 13 years at Rutgers University and has been an author on over 60 publications including guidelines for assessing the efficacy of new drugs in prostate cancer and recommendations for the use of immunotherapy to treat prostate cancer. Dr. Stein is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), and Prostate Cancer.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

Thomas C Randall, MD is a gynecologic oncologist focused on meeting the individual needs and goals of women with gynecologic cancers. Dr. Randall provides care for all gynecologic cancers and for women at increased risk for gynecologic cancers. He has a particular focus on providing safe surgical care for women with gynecologic cancers, including advanced or recurrent ovarian cancer, uterine, cervical and vulvar cancer. Dr. Randall also performs surgery for complex gynecologic conditions. He has extensive experience and expertise in minimally invasive surgeries, and he has performed over 1000 surgeries with the DaVinci surgical robot. Additionally, Dr. Randall has expertise in radical cancer surgeries, including fertility sparing surgeries for gynecologic cancers.Dr. Randall studied at Bowdoin College where he graduated Magna Cum Laude with Honors in English Literature and won the College Prize for Bowdoin from the Academy of American Poets. He then attended Johns Hopkins University School of Medicine and completed his residency in Obstetrics and Gynecology at Johns Hopkins Hospital. Next, he completed his fellowship in Gynecologic Oncology at the University of Pennsylvania in Philadelphia. Dr. Randall practiced gynecologic oncology and gynecologic surgery at the University of Pennsylvania and the Massachusetts General Hospital before coming to Columbia.Dr. Randall is a leader in global health. He is the Chair of the Mentorship and Training Committee of the International Gynecologic Cancer Society, which supports 22 gynecologic oncology fellowships in low- and middle-income countries where gynecologic cancer surgery was not previously available. He also serves as an international mentor for gynecologic oncology fellowships in Haiti and Rwanda. Dr. Randall is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Cervical Cancer, Ovarian Cancer, Vulvar Cancer, Oophorectomy, and Hysterectomy.

Deaglan Mchugh is an Oncologist in New York, New York. Dr. Mchugh has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Teratoma of the Mediastinum, and Prostatectomy. Dr. Mchugh is currently accepting new patients.

Stephen Trauzzi is a Urologist in New Rochelle, New York. Dr. Trauzzi is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Prostatectomy, and Ureteroscopy.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Joel Sheinfeld is a Urologist in New York, New York. Dr. Sheinfeld is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Choriocarcinoma, Orchiectomy, and Lymphadenectomy. Dr. Sheinfeld is currently accepting new patients.

Darren Feldman is an Oncologist in New York, New York. Dr. Feldman is rated as a Distinguished provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Testicular Cancer, Teratoma of the Mediastinum, Renal Cell Carcinoma (RCC), Orchiectomy, and Nephrectomy. Dr. Feldman is currently accepting new patients.

Gary Goldberg is a Urologist in Manhasset, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Reconstructive Urology Surgery.

Robert Alter is an Otolaryngologist in Hackensack, New Jersey. Dr. Alter is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Urothelial Cancer, Endoscopy, and Nephrectomy.

Jonathan Fleischmann is a Urologist in Bronx, New York. Dr. Fleischmann is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Boils, Carbuncle, Folliculitis, and Reconstructive Urology Surgery.

Rosa Nouvini is an Oncologist in New York, New York. Dr. Nouvini is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Choriocarcinoma. Dr. Nouvini is currently accepting new patients.

Norman Rosen is an Oncologist in Yonkers, New York. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, GTP Cyclohydrolase 1 Deficiency, Glyceraldehyde-3-Phosphate Dehydrogenase Deficiency, and Bone Marrow Aspiration.

Dimitri Kessaris is a Urologist in Manhasset, New York. Dr. Kessaris is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), and Urinary Incontinence.

Dr Steven Berman has been in practice for 25 years specializing in General Urology. Dr. Berman is rated as an Experienced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, and Urinary Tract Infection in Children.

Dr. Dan Costin is Director of the White Plains Hospital Center for Cancer Care. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007. Dr. Costin is rated as an Advanced provider by MediFind in the treatment of Choriocarcinoma. His top areas of expertise are Paget Disease of the Breast, Chondrosarcoma, Osteosarcoma, and Angiosarcoma.